Halfway through this medium post he refers to using proteomics to identify vaccine induced allergies early, and thus shorten the clinical trial timelines needed to assess candidates. What is meant by this exactly? Is it feasible/are we close to this kind of technology? What about antibody-dependent enhancement? Just an undergrad here, would appreciate your expert opinions.
https://medium.com/@hannu_64912/six-months-to-a-vaccine-7ebc9e9018a8